Tag Archives: Product recall

GM Recalls Vehicles for Sun Visor Warning

25 Nov

by Ken Davidson

General Motors will be recalling over 18,000 2013 and 2014 Chevrolet Camaro vehicles due to a “safety defect.” The automaker notified the NHTSA in September 2013 that:

General Motors has decided that certain 2013-2014 model year Chevrolet
Camara Coupe vehicles may fail to conform to Federal Motor Vehicle Safety Standard 208
for Occupant Crash Protection. These vehicles were built with one or two sun visors that
may have air bag warning labels that were not properly adhered See the full recall letter here

The gist of the recall: Warning labels attached to sun visors may peel.

General Motors also stopped production of Chevrolet Camaro’s due to the defect.

2013 and 2014 Chevrolet Camaro Recalled

2013 and 2014 Chevrolet Camaro Recalled

Schererville Police Charge Joel Hill With Armed Robbery

6 Nov

Gazette Staff

 

On November 6th, 2013 Schererville Detectives filed 5 Class B Felony counts against Joel B. Hill age 19, of Schererville, In..

The charges included: Armed Robbery
Attempted Armed Robbery
Criminal Confinement (3 Counts)

The charges are a result of the investigation into an Armed robbery that occurred on October 18th,2013 at the CHASE Bank located at 1801 Kennedy Avenue, in Schererville, In.. During the Robbery the suspect approached the victims vehicle as they were attempting to use the outside ATM at that location. The suspect approached the driver’s side of the vehicle, pointed a handgun at the driver and took the $40 in cash that she had just removed from the machine.   The suspect then ordered the driver to attempt to make another withdrawal using one of the passengers bank cards. After several unsuccessful attempts to get money from the machine, the suspect ordered them to leave. The three occupants of the vehicle came immediately to the police department to report the incident.
During the investigation of this Robbery, Detectives were able to develop a suspect through confidential information and believed that Joel B. Hill was responsible. The victims were able to positively identify Hill as the person whom robbed them at CHASE Bank, from a photo line-up.

Joel Hill is currently confined at Lake County Jail after being charged with Burglary on October 25th, 2013 in reference to a burglary that occurred on July19th, 2013 in the 100 block of Seville St. in Schererville, In..

Any questions or information please contact:

Brian Neyhart
Patrol Commander
Schererville Police Department
25 E. Joliet St.
Schererville, IN 46375
219-322-5000

Please Like Us on:
Facebook

Infant Acetamenophin Sold by Local Retailers Recalled

3 Nov

 

Walgreens, Kroger, Meijer and Babies R Us brands are among the listed batches of infant acetamenophin recalled today by manufacturer Perrigo.  The Kroger brand is sold locally at Food4Less stores.  While the product does not appear to be defective, the recall notice was issued because some packages may contain unmarked syringes.  The company warns that unmarked dosing syringes should not be used.  If you have a product that has dosage markings on the syringe, it is perfectly safe to use according to the release.  The complete list of brands and lot numbers is:

Label Batches
BABIES R US 3KK0606
CARE ONE 3HK0564
EQUALINE 3HK0672
EQUATE 3HK0672, 3JK0433, 3JK0594, 3JK0595, 3JK0653, 3JK0673, 3KK0815, 3KK0817
HARMON FACE VALUES 3JK0594
HEALTH MART 3HK0671
HEALTHY ACCENTS 3HK0671, 3KK0606
HEB 3KK0606
KROGER 3GK0645, 3GK0704, 3HK0671, 3JK0433, 3JK0595, 3JK0653, 3JK0433, 3JK0595, 3GK0645, 3GK0704, 3JK0595
LEADER DRUG 3JK0433, 3JK0594
MEIJER 3JK0594, 3JK0597
PUBLIX 3JK0595
RITE AID 3GK0704
TOPCARE 3KK0359, 3KK0494
UP & UP 3HK0672
WALGREEN 3GK0704, 3HK0564, 3HK0671, 3JK0433, 3JK0595, 3JK0610, 3KK0360

In a statement, the company said:

The Perrigo Company (NYSE: PRGO; TASE) announced today that it has initiated a voluntary, nationwide product recall to the retail level of 18 batches of its acetaminophen infant suspension liquid, 160 mg/5 mL, sold in 2 oz. and 4 oz. bottles with syringes in a box under the store brand products listed below above. The recall is being initiated because of the remote potential that a small number of packages might contain an oral dosing syringe without dose markings. The correct syringe should have a white or yellow plunger with specific dose markings for 1.25 mL, 2.5 mL, 3.75 mL, and 5 mL. If the product’s syringe has these dose markings, consumers can continue to use the product while following labeled use instructions.

Using an oral syringe without dose markings can result in inaccurate dosing, especially in infants who could mistakenly get too high a dose.

Commenting on this market action, Perrigo’s Chairman, President and CEO Joseph C. Papa stated, “There are no issues or concerns with respect to the safety or efficacy of the product, only the potential that the oral dosing device in a relatively small number of packages could be unmarked. Out of an abundance of caution, we are taking this measure to maintain the highest possible product quality standards for our retail customers and consumers. While we cannot be certain that any of these unmarked dosing devices were released into our customers’ supply chains, taking this action is the right thing to do.” Perrigo has not received any reports or complaints related to this defect nor have they found any product with missing dose markings on re-examination of product on hand.

This OTC product is indicated for the relief of fever and minor aches and pains and can be used in infants, children and adults. These recalled products are sold by distributors nationwide and distributed through retail stores.

Perrigo is notifying its distributors and customers by verbal and e-mail communication today, followed by formal FedEx-delivered communication. It also is arranging for return of all recalled products. Distributors/retailers that have the acetaminophen infant suspension liquid that is being recalled should stop distribution and return product.

If the oral dosing device contained in the package has dose markings, no action is required, and the consumer can continue to use the product consistent with the label instructions. If the package contains an oral dosing device that does not have dose markings, the consumer should not use the product and should call Perrigo’s Consumer Affairs Department, toll free, 1-800-719-9260. Consumers should contact their physician or healthcare provider if they have any questions, or if they or their children experience any problem that could possibly be related to this drug product.

Adverse events that may be related to the use of this product may be reported to FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.